BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $140 at Truist Securities
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $67.85 +1.82%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 12 | New: 26
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 12 | New: 26
Join SI Premium – FREE
Truist Securities analyst Robyn Karnauskas raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $140.00 (from $135.00) while maintaining a Buy rating.
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $88 at Piper Sandler
- SmartFinancial (SMBK) PT Raised to $60 at Benchmark on Higher Valuation
- Venu Holding (VENU) PT Lowered to $8.70 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
